Toho Holdings Reports Fiscal Year 2025 Financial Results with Mixed Performance

Toho Holdings Co., Ltd. ( (JP:8129) ) just unveiled an update.

Toho Holdings Co., Ltd. reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a slight increase in net sales by 2.8% to ¥1,518,495 million. However, there was a decline in operating profit and ordinary profit by 2.0% and 4.9% respectively. The company also noted a significant drop in comprehensive income by 21.9%. Despite these challenges, Toho Holdings increased its annual dividend per share to ¥65.00, reflecting a commitment to shareholder returns. The financial forecast for the next fiscal year indicates a positive outlook with expected growth in net sales and profits, although profit attributable to owners of the parent is projected to decrease by 20.9%.

The most recent analyst rating on (JP:8129) stock is a Hold with a Yen4320.00 price target. To see the full list of analyst forecasts on Toho Holdings Co., Ltd. stock, see the JP:8129 Stock Forecast page.

More about Toho Holdings Co., Ltd.

Toho Holdings Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily operating in the pharmaceutical industry. It focuses on the distribution and sale of pharmaceutical products and related services, aiming to cater to the healthcare market.

Average Trading Volume: 180,691

Technical Sentiment Signal: Buy

Current Market Cap: Yen301.1B

Learn more about 8129 stock on TipRanks’ Stock Analysis page.